浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2012年
23期
1871-1873
,共3页
戴俏琼%叶再元%陶厚权%邵钦树
戴俏瓊%葉再元%陶厚權%邵欽樹
대초경%협재원%도후권%소흠수
氟尿嘧啶%顺铂%胃癌%MicroRNA
氟尿嘧啶%順鉑%胃癌%MicroRNA
불뇨밀정%순박%위암%MicroRNA
Fluorouracil%Cisplatin%Gastric cancer%MicroRNA
目的通过分析氟尿嘧啶(5-Fu)联合顺铂(DDP)对胃癌细胞 microRNAs 表达谱的影响,探讨其治疗的分子机制.方法 MTT 法检测不同浓度5-Fu(终浓度分别为80、40、20、10、5、2.5μg/ml)和 DDP (终浓度分别为1.6、0.8、0.4、0.2、0.1、0.05μg/ml)作用下人胃癌细胞株9811P 增殖情况;用 IC50浓度的5-Fu和 DDP 干预9811P 细胞48h 后,利用 miRNA 芯片检测用药前后9811P 细胞 miRNAs 表达的差异;并用实时定量 RT-PCR 进行验证.结果5-Fu及 DDP 与人胃癌细胞株9811P 生长抑制率之间有浓度依赖关系,48h 的 IC50值分别为7.68、0.59μg/ml;分别用 IC50浓度的5-Fu和 DDP 干预细胞48h 后筛到29个与5-Fu干预相关 miRNAs,27个与 DDP 干预相关 miRNAs,应用实时定量 PCR 来验证了5-Fu和 DDP 组均显著上调的3个 miRNAs (miR-31、miR-96和 miR-141),结果与芯片结果一致.通过 TargetScan 等软件对 miR-96靶基因进行预测,共筛选出8个靶基因的生物学功能与胃癌相关.结论5-Fu和顺铂对胃癌细胞 miRNAs 的表达谱有影响,可能是5-Fu 和顺铂抑制胃癌细胞生长的作用途径之一.
目的通過分析氟尿嘧啶(5-Fu)聯閤順鉑(DDP)對胃癌細胞 microRNAs 錶達譜的影響,探討其治療的分子機製.方法 MTT 法檢測不同濃度5-Fu(終濃度分彆為80、40、20、10、5、2.5μg/ml)和 DDP (終濃度分彆為1.6、0.8、0.4、0.2、0.1、0.05μg/ml)作用下人胃癌細胞株9811P 增殖情況;用 IC50濃度的5-Fu和 DDP 榦預9811P 細胞48h 後,利用 miRNA 芯片檢測用藥前後9811P 細胞 miRNAs 錶達的差異;併用實時定量 RT-PCR 進行驗證.結果5-Fu及 DDP 與人胃癌細胞株9811P 生長抑製率之間有濃度依賴關繫,48h 的 IC50值分彆為7.68、0.59μg/ml;分彆用 IC50濃度的5-Fu和 DDP 榦預細胞48h 後篩到29箇與5-Fu榦預相關 miRNAs,27箇與 DDP 榦預相關 miRNAs,應用實時定量 PCR 來驗證瞭5-Fu和 DDP 組均顯著上調的3箇 miRNAs (miR-31、miR-96和 miR-141),結果與芯片結果一緻.通過 TargetScan 等軟件對 miR-96靶基因進行預測,共篩選齣8箇靶基因的生物學功能與胃癌相關.結論5-Fu和順鉑對胃癌細胞 miRNAs 的錶達譜有影響,可能是5-Fu 和順鉑抑製胃癌細胞生長的作用途徑之一.
목적통과분석불뇨밀정(5-Fu)연합순박(DDP)대위암세포 microRNAs 표체보적영향,탐토기치료적분자궤제.방법 MTT 법검측불동농도5-Fu(종농도분별위80、40、20、10、5、2.5μg/ml)화 DDP (종농도분별위1.6、0.8、0.4、0.2、0.1、0.05μg/ml)작용하인위암세포주9811P 증식정황;용 IC50농도적5-Fu화 DDP 간예9811P 세포48h 후,이용 miRNA 심편검측용약전후9811P 세포 miRNAs 표체적차이;병용실시정량 RT-PCR 진행험증.결과5-Fu급 DDP 여인위암세포주9811P 생장억제솔지간유농도의뢰관계,48h 적 IC50치분별위7.68、0.59μg/ml;분별용 IC50농도적5-Fu화 DDP 간예세포48h 후사도29개여5-Fu간예상관 miRNAs,27개여 DDP 간예상관 miRNAs,응용실시정량 PCR 래험증료5-Fu화 DDP 조균현저상조적3개 miRNAs (miR-31、miR-96화 miR-141),결과여심편결과일치.통과 TargetScan 등연건대 miR-96파기인진행예측,공사선출8개파기인적생물학공능여위암상관.결론5-Fu화순박대위암세포 miRNAs 적표체보유영향,가능시5-Fu 화순박억제위암세포생장적작용도경지일.
[ ] Objective To investigate the effect of 5-fluorouracil (5-Fu) and cisplatin (DDP) on the expression profiles of miRNAs in human gastric cancer cel s. Methods The anti-tumor effect of 5-Fu and DDP on gastric cancer 9811P cel s was an-alyzed by MTT and IC50 values of both drugs were calculated. The differential expression of miRNAs were analyzed by miRNA mi-croarray, RT-PCR and verified by RT-PCR. Results IC50 values of 5-Fu and DDP for the 9811P cel s were 7.68μg/ml and 0.59μg/ml respectivelyt. Compared to controls 29 and 27 of miRNAs in gastric cancer 9811P cel s were identified as differential y expressed after exposed to 5-Fu or cisplatin, respectively. miR-31, miR-96, miR-141 were up-regulated in cel lines both after treatment of 5-Fu or DDP, which were validated by RT-PCR. Prediction of miR-96 with TargetScan software revealed that 8 genes might be related to biological behavior of gastric cancer. Conclusion 5-Fu and DDP can modify the expression profiles of miRNAs in gastric cancer cel s, which may be partial y associate with their pharmacological effects.